FURIEX PHARMACEUTICALS INC's ticker is FURX and the CUSIP is 36106P101. A total of 108 filers reported holding FURIEX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 7.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $85,371,000 | +4575.3% | 804,024 | +3730.9% | 0.12% | +3766.7% |
| Q1 2014 | $1,826,000 | +103.1% | 20,988 | -1.9% | 0.00% | +200.0% |
| Q4 2013 | $899,000 | -24.6% | 21,391 | -21.1% | 0.00% | -50.0% |
| Q3 2013 | $1,193,000 | -25.4% | 27,114 | -42.2% | 0.00% | -33.3% |
| Q2 2013 | $1,600,000 | – | 46,948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Magnetar Financial LLC | 950,000 | $100,871,000 | 1.68% |
| Camber Capital Management LP | 200,000 | $21,236,000 | 1.39% |
| OXFORD ASSET MANAGEMENT LLP | 378,901 | $40,080,000 | 1.30% |
| Magnetar Financial LLC | 734,006 | $77,937,000 | 1.30% |
| HARVEST MANAGEMENT LLC | 10,077 | $1,070,000 | 1.08% |
| FRANKLIN STREET ADVISORS INC /NC | 48,755 | $5,177,000 | 0.99% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 251,319 | $26,685,000 | 0.78% |
| Biondo Investment Advisors, LLC | 19,385 | $2,058,000 | 0.65% |
| Andromeda Capital LLC | 75,100 | $7,974,000 | 0.56% |
| CSS LLC/IL | 126,200 | $13,399,000 | 0.56% |